First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 tria... by Cytryn, Samuel L, MD, Moy, Ryan H, MD, Cowzer, Darren, MBBCh, Shah, Ronak H, MS, Chou, Joanne F, MPH, Joshi, Smita S, MD, Ku, Geoffrey Y, MD, Maron, Steven B, MD, Desai, Avni, MD, Yang, Jessica, MD, Sugarman, Ryan, MD, Rao, Devika, MD, Goldberg, Zoe, MD, Charalambous, Carmelina, MPhil, Lapshina, Maria, BE, Antoine, Ariel, BS, Socolow, Fiona, BA, Trivedi, Nikhil, BS, Capanu, Marinela, PhD, Gerdes, Hans, Prof, Schattner, Mark A, Prof, Simmons, Marc, MD, Lacouture, Mario E, MD, Paroder, Viktoriya, MD, Tang, Laura H, Prof, Shia, Jinru, Prof, Ilson, David H, Prof, Solit, David B, Prof, Berger, Michael F, PhD, Janjigian, Yelena Y, MD

Get full text